Living Donor Liver Transplantation Following Transcatheter Aortic Valve Implantation for Aortic Valvular Disease.


Journal

Seminars in cardiothoracic and vascular anesthesia
ISSN: 1940-5596
Titre abrégé: Semin Cardiothorac Vasc Anesth
Pays: United States
ID NLM: 9807630

Informations de publication

Date de publication:
Sep 2020
Historique:
pubmed: 28 11 2019
medline: 8 6 2021
entrez: 28 11 2019
Statut: ppublish

Résumé

Over the last few decades, outcomes with living donor liver transplantation (LDLT) have improved significantly. This has resulted in patients who were denied liver transplantation previously, due to various comorbidities and high risk, now being considered for LDLT. This includes patients with severe valvular heart disease such as aortic stenosis. These patients require aortic valve replacement to help cope with significant perioperative hemodynamic changes. High-risk cardiac procedures like aortic valve replacement are associated with serious perioperative morbidity and mortality in patients with end-stage liver disease. Since the advent of transcatheter aortic valve implantation (TAVI) in 2002, there have been a few case reports of its successful use prior to deceased donor liver transplantation, but there is no literature on this procedure before LDLT. In this article, we report our experience with 2 patients, the first patient with infective endocarditis-induced acute aortic regurgitation and the second patient with bicuspid aortic stenosis who underwent uneventful TAVI followed by successful LDLT. In conclusion, with the increasing expertise and experience in this procedure, an increasing number of potential recipients, previously considered as high-risk transplant candidates, can now be offered liver transplantation by performing pretransplant TAVI.

Identifiants

pubmed: 31771417
doi: 10.1177/1089253219887162
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

273-278

Auteurs

Ilankumaran Kaliamoorthy (I)

Dr Rela Institute and Medical Center, Bharath Institute of Higher Education and Research, Chennai, India.

Akila Rajakumar (A)

Dr Rela Institute and Medical Center, Bharath Institute of Higher Education and Research, Chennai, India.

Joye Varghese (J)

Gleneagles Global Health City, Chennai, India.

Susan George (S)

Gleneagles Global Health City, Chennai, India.

Mohamed Rela (M)

Dr Rela Institute and Medical Center, Bharath Institute of Higher Education and Research, Chennai, India.
King's College Hospital, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH